Free Trial

Senti Biosciences (SNTI) Competitors

Senti Biosciences logo
$1.64 +0.06 (+3.46%)
Closing price 04:00 PM Eastern
Extended Trading
$1.64 -0.01 (-0.36%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SNTI vs. SLS, FTLF, MEIP, LXEO, THTX, CLLS, ENTA, KRRO, MOLN, and BHST

Should you be buying Senti Biosciences stock or one of its competitors? The main competitors of Senti Biosciences include SELLAS Life Sciences Group (SLS), FitLife Brands (FTLF), MEI Pharma (MEIP), Lexeo Therapeutics (LXEO), Theratechnologies (THTX), Cellectis (CLLS), Enanta Pharmaceuticals (ENTA), Korro Bio (KRRO), Molecular Partners (MOLN), and BioHarvest Sciences (BHST). These companies are all part of the "pharmaceutical products" industry.

Senti Biosciences vs. Its Competitors

SELLAS Life Sciences Group (NASDAQ:SLS) and Senti Biosciences (NASDAQ:SNTI) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, media sentiment, earnings and profitability.

SELLAS Life Sciences Group's return on equity of -132.51% beat Senti Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
SELLAS Life Sciences GroupN/A -132.51% -92.79%
Senti Biosciences N/A -223.98%-76.02%

17.4% of SELLAS Life Sciences Group shares are held by institutional investors. Comparatively, 25.7% of Senti Biosciences shares are held by institutional investors. 1.4% of SELLAS Life Sciences Group shares are held by company insiders. Comparatively, 3.1% of Senti Biosciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, SELLAS Life Sciences Group had 2 more articles in the media than Senti Biosciences. MarketBeat recorded 4 mentions for SELLAS Life Sciences Group and 2 mentions for Senti Biosciences. SELLAS Life Sciences Group's average media sentiment score of 0.81 beat Senti Biosciences' score of 0.68 indicating that SELLAS Life Sciences Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SELLAS Life Sciences Group
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Senti Biosciences
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

SELLAS Life Sciences Group has a beta of 2.26, meaning that its share price is 126% more volatile than the S&P 500. Comparatively, Senti Biosciences has a beta of 2.07, meaning that its share price is 107% more volatile than the S&P 500.

SELLAS Life Sciences Group has higher earnings, but lower revenue than Senti Biosciences. SELLAS Life Sciences Group is trading at a lower price-to-earnings ratio than Senti Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SELLAS Life Sciences Group$1M201.12-$30.88M-$0.32-5.97
Senti Biosciences$2.56M16.81-$52.79M-$8.95-0.18

SELLAS Life Sciences Group presently has a consensus price target of $7.00, indicating a potential upside of 266.49%. Senti Biosciences has a consensus price target of $8.50, indicating a potential upside of 416.72%. Given Senti Biosciences' higher probable upside, analysts clearly believe Senti Biosciences is more favorable than SELLAS Life Sciences Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SELLAS Life Sciences Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Senti Biosciences
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

SELLAS Life Sciences Group and Senti Biosciences tied by winning 7 of the 14 factors compared between the two stocks.

Get Senti Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNTI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNTI vs. The Competition

MetricSenti BiosciencesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$41.60M$3.11B$5.76B$9.58B
Dividend YieldN/A2.23%4.41%4.09%
P/E Ratio-0.1820.8831.1026.05
Price / Sales16.81356.38436.12105.98
Price / CashN/A43.1937.7358.48
Price / Book1.758.129.536.61
Net Income-$52.79M-$54.72M$3.26B$265.56M
7 Day Performance8.22%2.62%2.11%1.98%
1 Month Performance-17.34%7.63%5.12%1.33%
1 Year Performance-38.62%13.11%31.25%21.15%

Senti Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SNTI
Senti Biosciences
2.8145 of 5 stars
$1.65
+3.5%
$8.50
+416.7%
-38.8%$41.60M$2.56M-0.184
SLS
SELLAS Life Sciences Group
2.9108 of 5 stars
$1.55
+0.3%
$7.00
+353.1%
+34.4%$154.16M$1M-4.0710
FTLF
FitLife Brands
4.1646 of 5 stars
$16.33
+4.5%
$20.50
+25.5%
+6.0%$153.34M$64.47M19.4420
MEIP
MEI Pharma
1.5017 of 5 stars
$4.68
-3.2%
N/A+47.1%$151.33M$65.30M-0.98100
LXEO
Lexeo Therapeutics
2.4216 of 5 stars
$4.52
+1.9%
$17.17
+279.5%
-62.3%$149.73M$650K-1.3758Analyst Revision
THTX
Theratechnologies
N/A$3.22
+0.5%
N/A+142.5%$147.83M$85.87M-16.92140News Coverage
Short Interest ↓
CLLS
Cellectis
3.4335 of 5 stars
$2.66
+0.2%
$4.00
+50.7%
+17.6%$147.57M$49.22M-3.24290Positive News
Short Interest ↓
ENTA
Enanta Pharmaceuticals
3.6602 of 5 stars
$6.81
+4.9%
$21.67
+218.2%
-32.4%$145.64M$67.64M-1.50160
KRRO
Korro Bio
1.3805 of 5 stars
$15.51
+3.1%
$102.43
+560.4%
-55.3%$145.64M$2.27M-1.6470
MOLN
Molecular Partners
2.4006 of 5 stars
$3.59
+3.3%
$12.00
+234.7%
-43.8%$144.76M$5.65M-1.87180News Coverage
Upcoming Earnings
Gap Up
BHST
BioHarvest Sciences
N/A$8.81
-0.1%
$13.67
+55.1%
N/A$144.66M$25.19M-17.62N/AGap Up

Related Companies and Tools


This page (NASDAQ:SNTI) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners